Author： Ekman P.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.18, Iss.3, 1998-03, pp. : 161-170
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Treatment options for benign prostatic hyperplasia
By Thurlow R.J.
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Dutasteride for the treatment of benign prostatic hyperplasia
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. :
Finasteride: An Update of its Use in the Management of Symptomatic Benign Prostatic Hyperplasia
Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. :
A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction
By Vitezic D.
Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. :